ArticleAmerican journal of clinical and experimental immunology2018

Posterior reversible encephalopathy syndrome (PRES) attributed to mycophenolate mofetil during the management of SLE: a case report and review.

Lei Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.